Chapter 13.3 Neoplastic proliferation of white cells Flashcards

1
Q

etiology and pathogenesis of white cell neoplasia–chromosomal translocations and other acquired mutations

A
  • nonrandom chromosomal abnormalities, most commonly translocations are present in the majority of white cell neoplasms!!
  • Many specific rearrangements are associated with particular neoplasms suggesting critical role in genesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The genes that are mutated or otherwise altered in white cell neoplasia often play crucial roles in?

A
  • development, growth or survival of normal counterpart of the malignant cell
  • consequently, certain mutations are associated with specific tumor types
  • sometimes, mutation produces a “dominant negative” protein that interferes with normal function (loss of function); in others the result is an inappropriate increase in some normal activity (gain of fnx)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

White cell neoplasia etiology–oncoproteins created by genomic aberrations often

A

-block normal maturation, turn on pro-growth signaling pathways or protect cells from apoptotic cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Oncogenic events that serve as oncogenic driver mutations in particular kinds of white cell malignancies

A
  • many oncoproteins cause arrest in differentiation when cells are proliferating rapidly–important in acute leukemias in which dominant negative oncogenic mutations involving transcription factors are present that interfere with early stages of lymphoid of myeloid cell differentiation
  • mutations in transcriptional regulators–enhance self renewal of tumor cells giving them stem-cell like properties; these mutations collaborate with mutations that produce a constituitively active tyrosine knase; downstream signaling arms, the PI3K/AKT and MAPK pathways and derive cell growth and Warburg metabolism
  • Mutations that inhibit apoptosis–certain hematologic malignancies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How are proto-oncogenes activated in lymphoid cells?

A

-by errors that occur during Ag receptor gene rearrangement and diversification!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Among lymphoid cells, potentially ocogenic mutations occur most frequently in

A

-germinal center B cells during attempted Ab diversification; after Ag stimulation, B cells enter germinal centers and upregulate the expression of activation-induced cytosine deaminase (AID), a specialized DNA-modifying enzyme that is essential for class switching and somatic hypermutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

class switching

A

-intragenic remcombination event where the IgM heavy chain constant gene segment is replaced with a different constant segment (IgG3) leading to a switch in the class (isotype) of Ab produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

somatic hypermutation

A

-creates point mutations within Ig genes that may increase Ab affinity for Ag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MYC protooncogene

A
  • activated in germinal center B-cell lymphomas by translocations to transcriptionally active Ig locus
  • AID expression is sufficient to induce MYC/Ig translocations in normal germinal center B cells, apparently because AID creates lesions in DNA that lead to chromosomal breaks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BCL6 protooncogene

A

-transcription factor that has important role in many B-cell malignancies; frequently activated in germinal center-B cell lymphomas by point mutations that also stem from mistargeted DNA breaks induced by AID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

regulated genomic instability unique to precursor B and T cells:

A
  • express a V(D)J recombinase that cuts DNA at specific sites within the Ig and T cell receptor loci, respectively
  • process is essential for the assembly of productive Ag receptor genes but sometimes goes awry leading to joining of portions of other genes to Ag receptor gene regulatory elements
  • esp in tumors of precursor T cells, proto-oncogenes are often deregulated by their involvement in aberrant recombination events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pathogenesis of white cell malignancies

A
  • tumors harbor mutations that principally effect maturation or enhance self-renewal, drive growth or prevent apoptosis
  • Progrowth mutations: tyrosine kinase mutations, MYC translocation–increased cell division, Warburg metabolism
  • Mutations in TFs that influence self renewal (MLL translocation, PML-RARA fusion gene)
  • Pro-survival mutations: BCL2 translocation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Inherited genetic factors in white cell neoplasias

A
  • ppl with genetic diseases that promote genomic instability such as Bloom syndrome, Fanconi anemia, and ataxia telangiectasia are at increased risk of acute leukemia
  • Also both Down syndrome and NF type 1 are associated with increased risk of childhood leukemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Viruses and white cell malignancies

A

-3 viruses: HTLV-1, EBV, and Kaposi sarcoma herpesvirus/ HHV8=causative agents in particular lymphomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HTLV-1 is associated with which malignancies?

A

-adult T-cell leukemia/lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

EBV associated with?

A

Burkitt lymphoma, 30-40% of Hodgkin lymphoma, many B-cell lymphomas arising in the setting of T-cell immunodeficiencies and rare NK-cell lymphomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

KSHV is associated with

A

-Kaposi sarcoma and unusual B-cell lymphoma that presents as a malignant effusion, often in the pleural cavity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Chronic inflammation and white cell malignancies

A
  • localized chronic inflammation predispose to lymphoid neoplasia–almost always arises within inflammed tissue
  • H. pylori–>gastric B cell lymphomas
  • gluten sensitive enteropathy–>intestinal T-cell lymphomas
  • breast implants–>unusual T cell lymphoma subtype
  • HIV infxn–> B cell lymphomas that may arise within any organ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

HIV infection and B cell lymphoma pathogenesis

A
  • early on, T-cell dysregulation of HIV causes a systemic hyperplasia of germinal center B cells that is associated with an increased incidence of germinal center B-cell lymphomas
  • In advanced infection (AIDS), severe T-cell deficiency further elevates risk for B-cell lymphomas, esp those associated with EBV and KSHV/HHV-8
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Iatrogenic factors and white cell malignancies

A

-radiation therapy and certain chemotherapies increase risk of myeloid and lymphoid neoplasms due to mutagenic effects of ionizing radiation and chemotherapeutic drugs on hematolymphoid progenitor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Smoking and white cell malignancies

A

-smokers have 1.3-2x increased incidence of acute myeloid leukemia bc of exposure to carcinogens like benzene in tobacco smoke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Lymphoid neiplasms–Leukemia vs. lymphoma definitions

A
  • Leukemia: neoplasms that present with widespread involvement of bone marrow and usually (but not always) the peripheral blood
  • Lymphoma: proliferations that arise in discrete tissue masses
  • blurred division bw the two
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Types of lymphomas

A
  • 2 broad categories: Hodgkin lymphoma and non-Hodgkin lymphomas
  • another group of B cell tumors which differs from most lymphomas is plasma cell neoplasms–arise in bone marrow and rarely involve lymph nodes or peripheral blood
24
Q

Clinical presentation of various lymphoid neoplasms is often determined by

A
  • anatomic distribution of disease
  • 2/3 of NHLs and all HLs present as enlarged nontender lymph nodes (>2 cm)
  • remaining 1/3 of NHLs present with symptoms related to involvement extranodal sites (skin, stomach or brain)
25
Q

Lymphocytic leukemias signs and symptoms

A
  • related to suppression of nomral hematopoeisis by tumor cells in the bone marrow
  • other symptoms related to lymphoid tumors are caused by proteins secrted from the tumor cells or from immune cells that are responding to the tumor–ex: plasma cell tumors where there is secretion of whole Abs or Ig fragments; HL associated with fever related to release of cytokines from inflammatory cells responding to release of tumor cells; peripheral T cell lymphomas where tumors of functional T cells release inflammatory cytokines and chemokines
26
Q

Most common plasma cell neoplasm

A
  • multiple myeloma

- causes bony destruction of the skeleton and presents with pain due to pathologic fractures

27
Q

WHO classification of lymphoid neoplasms–5 categories seperated according to cell of origin:

A

1) Precursor B cell neoplasms (neoplasms of immature B cells)
2) Peripheral B-cell neiplasms (neoplasms of mature B-cells)
3) Precursor T-cell neoplasms (neoplasms of immature T cells)
4) peripheral T cell and NK cell neoplasms (neoplasms of mature T cells and NK cells)
5) Hodgkin lymphoma (neoplasms of Reed-Sternberg cells and variants)

28
Q

What is needed to Dx lymphoid neoplasia

A

-can be suspected from clinical features but need histological exam of lymph nodes or other involved tissue!!

29
Q

Neoplasms from the bone marrow

A
  • BLB–>precursor lymphoblastic lymphoma/leukemias
  • NBC–>small lymphocytic lymphoma, chronic lymphocytic leukemia
  • PC–> Multiple myeloma
30
Q

neoplasms from the thymus

A

-DN–>DP–>precursor T lymphoblastic lymphoma/leukemia

31
Q

Neoplasms from the lymph node

A
  • MC–>Mantle cell lymphoma
  • GC–>follicular lymphoma, Burkitt lymphoma, diffuse large B cell lymphoma, Hodgkins lymphoma
  • MZ–>diffuse large B cell lymphoma, small lymphocytic lymphoma, chronic lymphocytic leukemia
  • PTC–>Peripheral T cell lymphomas
32
Q

Antigen receptor gene rearrangement generally precedes

A
  • transformation of lymphoid cells so all daughter cells derived from the malignant progenitor share the same Ag receptor gene configuration and sequence and synthesize identical Ag receptor proteins (either Igs or T cell receptors)
  • In contrast, normal immune responses are comprised of polyclonal populations of lymphocytes that express many different Ag receptors
  • analyses of Ag receptor genes and their protein products can be used to distinguish reactive (polyclonal) and malignant (monoclonal) lymphoid proliferations
  • Also, each Ag receptor gene rearrangement produces a unique DNA sequence that constitutes a highly specific clonal marker, which can be used to detect small numbers of reisdual malignant lymphoid cells after therapy
33
Q

Most lymphoid neoplasms resemble

A
  • some recognizable stage of B or T cell differentiation–used for classification
  • majority (85-90%) are of B cell origin with rest being T-cell tumors; NK origin tumors are RARE
34
Q

Lymphoid neoplasms are often associated with

A
  • immune abnormalities
  • Both a loss of protective immunity (susceptibility to infection) and a breakdown of tolerance (autoimmunity) can be seen, sometimes in same patient
  • pts with acquired immunodeficiency are at high risk of developing certain lymphoid neoplasms, esp those caused by oncogenic viruses (EBV)
35
Q

Neoplastic B and T cells tend to

A
  • recapitulate the behavior of their normal counterparts
  • Like normal lymphocytes, neoplastic B and T cells home to certain tissue sites leading to characteristic patterns of involvement
  • Ex: follicular lymphomas home to germinal centers in lymph nodes while cutaneious T cell lymphomas home to skin
  • Like their normal counterparts, particular adhesion molecules and chemokine receptors govern the homing of the neoplastic B and T lymphoid cells also recirculate through lymphatics and peripheral blood to distant sites–most lymphoid tumors are widely disseminated at time of Dx; exceptions=HLs which are sometimes restricted to one group of lymph nodes and marginal zone B cell lymphomas which are restricted to sites of chronic inflammation
36
Q

HL vs. NHL spread

A

-HLs spreads in an orderly fashion whereas NHL spreads widely early in their course in a less predictable fashion thus lymphoma staging is of most utility in guiding therapy in Hodgkin lymphoma

37
Q

Precursor B and T cell Neoplasms–Acute lymphoblastic leukemia/lymhomas (ALLs) are neoplasms composed of

A
  • immature B (pre-B) or T (pre-T) cells which are called lymphoblasts
  • 85% are B-ALLs which typically manifest as childhood acute leukemias; the less common T-ALLs present in adolescent males as thymic lymphomas
  • clinical overlap bw B and T-ALL
  • B-ALL uncommonly presents as a mass in the skin or bone and many T-ALLs present with or evolve to a leukemic picture
38
Q

The most common cancer of children

A
  • ALL!!
  • most occur in children under 15 yrs ; 3x more common in whites than in blacks and is more frequent in boys than girls
  • Hispanics have the highest incidence of any ethnic group
  • B-ALL peaks at age 3 bc the number of normal bone marrow pre-B cells (cell of origin) is greatest very early in life
  • peak incidence of T-ALL is adolescence, the age when thymus reaches max size
  • B and T-ALL also occur less frequently in adults of all ages
39
Q

Pathogenesis of ALL–many of the chromosomal aberrations seen in ALL do what?

A

-dysregulate the expression and function of transcription factors required for normal B and T cell development

40
Q

T-ALL mutations vs. most B-ALL mutations

A
  • 70% of T-ALL mutation: gain of function mutations in NOTCH1, a gene that is essential for T-cell development
  • B-ALL: loss of function mutations in genes that are required for B-cell development such as PAX5, E2A, and EBF or a balanced t (12;21) involving genes ETV6 and RUNX1–two genes that are needed in very early hematopoietic precursors
  • all of these mutations disturb differentiation and promote maturation arrest and induce increased self-renewal, a stem-cell like phenotype; similar themes in AML
41
Q

ALL–can single mutations cause it?

A
  • NO!
  • need complementary mutations–aberrations that drive cell growth like mutations that increase tyrosine kinase activity and RAS signaling are commonly present
  • fewer than 10 mutations are sufficient to produce full blown ALL so compared to solid tumors, ALL is a genetically simple tumor
42
Q

Chromosomal changes in ALLs

A
  • 90% have numerical or structural chromosomal changes–most common is hyperploidy and a variety of balanced chromosomal translocations also seen
  • changes in chromosome numbers correlate with immunophenotype and prognosis
  • hyperdiploidy and hypodiploidy are seen only in B-ALL
  • Also B and T ALL are associated with completely different sets of translocations indicating they are pathologically distinct
43
Q

Morphology of ALL

A
  • leukemic: marrow is hyper cellular and packed with lymphoblasts which replace the normal marrow elements
  • Mediastinal thyme masses occur in 50-70% of T-ALLs which are more likely to be associated with lymphadenopathy and splenomegaly
  • In both B- and T ALLs the tumor cells have scant basophilic cytoplasm and nuclei somewhat larger than those of small lymphocytes
  • the nuclear chromatin is delicate and finely stippled and nucleoli are usually small and often demarcated by a rim of condensed chromatin
44
Q

Morphology of ALL contd

A
  • many times, nuclear membrane is deeply subdivided imparting a convoluted appearance
  • aggressive clinical behavior so mitotic rate is high
  • interspersed macrophages ingesting apoptotic tumor cells may impart a starry sky appearance
45
Q

ALL and AML have different responses to chemotherapy so need to distinguish the two…how?

A
  • AML is a neoplasm of immature myeloid cells that can cause identical signs and symptoms
  • compared with myeloblasts, lymphoblasts have more condensed chromatin, less conspicuous nucleoli and smaller amounts of cytoplasm that usually lacks granules
  • these morphologic distinctions are not absolute and definitive diagnosis relies on stains with Abs for B and T cell Ags
  • Also histochemical stains useful bc in contrast to myeloblasts, lymphoblasts are myeloperoxidase negative and often have periodic acid Schiff positive cytoplasmic material
46
Q

Immunophenotype of ALL

A
  • immunostaining for terminal deoxynucleotidyl transferase (TdT), a specialized DNA polymerase that is expressed only in pre-B and pre-T lymphoblasts, is positive in more than 95% of cases
  • B and T ALLs are distinguished with stains for B and T cell specific markers
47
Q

B-ALL markers

A
  • B-ALLs arrested at various stages of pre-B cell dev
  • lymphoblasts express CD19 and TF PAX5 and CD10
  • In very immature B-ALLs, CD10 is negative
  • Alternatively, more mature late pre-B ALLs express CD10, CD19, CD20, and cytoplasmic IgM heavy chain (mu chain)
48
Q

T-ALL markers

A
  • arrested at various stages of pre-T cell dev
  • positive for CD1, CD2, CD5, and CD7
  • more immature tumors are negative for surface CD3, CD4, and CD8 whereas late pre-T cell tumors are positive for these markers
49
Q

Clinical features of ALL

A
  • similar for ALL and AML even though they are immunophenotypically and genetically distinct
  • In both, the accumulation of neoplastic “blasts” in the bone marrow suppresses normal hematopoiesis by physical crowding, competition for growth factors and other poorly understood mechanisms
50
Q

Common clinical features that are more characteristic features of ALL

A
  • Abrupt stormy onset within days to weeks of first S/S
  • Symptoms related to depression of marrow fnx including fatigue due to anemia; fever, reflecting infections secondary to neutropenia and bleeding due to thrombocytopenia
  • Mass effects caused by neoplastic infiltration which are more common in ALL including bone pain resulting from marrow expansion and infiltration of the subperiosteum; generalized lymphadenopathy, splenomegaly, and hepatomegaly; testicular enlargement and in T-ALL complications related to compression of large vessels and airways in mediastinum
  • CNS manifestations like HA, vomiting and nerve palsies resulting from meningeal spread –more common in ALL
51
Q

Prognosis of ALL

A

-Pediatric ALL: 95% of children with ALL obtain complete remission and 75-85% are cured but ALL remains leading cause of cancer deaths in children and only 35-40% are cured

52
Q

Factors associated with a worse prognosis for ALL

A
  • age younger than 2 yrs bc of strong association of infantile ALL with translocations involving the MLL gene
  • presentation in adolescence or adulthood
  • peripheral blood blast counts greater than 100,000 which reflects a high tumor burden
53
Q

Factors associated with favorable prognosis of ALL

A
  • age between 2 and 10 years
  • low white cell count
  • hyperdiploidy
  • trisomy of chromosomes 4,7, and 10
  • presence of a t(12;21)

**molecular detection of residual disease after Tx is predictive of a worse outcome in both B and T ALL

54
Q

Although most chromosomal aberrations in ALL alter the function of transcription factors, the t(9;22) does what?

A
  • creates a fusion gene that encodes a constitutively active BCR-ABL tyrosine kinase
  • In B-ALL, the BCR-ABL protein is smaller and has stronger tyrosine kinase activity than the form of BCR-ABL found in chronic myelogenous leukemia
55
Q

Treatment of t(9;22) positive B-ALL and outlook

A
  • BCR-ABL kinase inhibitors
  • outlook for adults with ALL is guarded because of differences in the molecular pathogenesis of adult and childhood ALL and also because adults cannot tolerate the intensive chemotherapy regimens that are curative in children